Literature DB >> 2891185

Circulating immunoreactive somatostatin in gastrointestinal diseases. Decrease after vagotomy and enhancement in active ulcerative colitis, irritable bowel syndrome, and duodenal ulcer.

J Binimelis1, S M Webb, J Monés, J Serrano, R Casamitjana, M Elena, M A Peinado, F Vilardell, A De Leiva.   

Abstract

The main source of circulating immunoreactive somatostatin (IRS) seems to be the gastrointestinal tract. We therefore investigated plasma IRS in patients with various gastrointestinal diseases. Mean basal IRS oscillated between 46 and 73 pg/ml. A postprandial rise was observed in all patients and age-matched controls. However, the increment was significantly higher in patients with duodenal ulcer (159 +/- 20 pg/ml), active ulcerative colitis (176 +/- 17 pg/ml), and irritable bowel syndrome (194.4 +/- 20.4 pg/ml). Patients with duodenal ulcers who underwent vagotomy showed a decreased postprandial increment (107 +/- 10 pg/ml) when compared with active duodenal ulcer patients. No difference was demonstrable between controls and individuals with gastric ulcer, and patients with inactive ulcerative colitis. These results suggest that vagal innervation plays a role in postprandial IRS stimulation, whereas gastric hyperacidity, acute lesions of the colonic mucosa, and hypermotility of the gastrointestinal tract are associated with an exaggerated postprandial IRS response. Since somatostatin is known to influence many gastrointestinal functions, these variations in circulating IRS concentrations may be of pathophysiologic importance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891185     DOI: 10.3109/00365528708991938

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.

Authors:  J J Worthington; F Reimann; F M Gribble
Journal:  Mucosal Immunol       Date:  2017-08-30       Impact factor: 7.313

2.  Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid through GPR120 in isolated gastric ghrelin cells and mice.

Authors:  Xinping Lu; Xilin Zhao; Jianying Feng; Alice P Liou; Shari Anthony; Susanne Pechhold; Yuxiang Sun; Huiyan Lu; Stephen Wank
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-07       Impact factor: 4.052

3.  Gastric argyrophil (enterochromaffin-like), gastrin, and somatostatin cells after proximal selective vagotomy in man.

Authors:  H Koop; M Frank; S Kuly; R Nold; R Eissele; G Rager; J Rüschoff; M Rothmund; R Arnold
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

4.  Octreotide effectively decreases mucosal damage in experimental colitis.

Authors:  R Eliakim; F Karmeli; E Okon; D Rachmilewitz
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

5.  Somatostatin in inflammatory bowel disease.

Authors:  J D van Bergeijk; J H Wilson
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

6.  Somatostatin does not attenuate intestinal injury in dextran sodium sulphate-induced subacute colitis.

Authors:  J D van Bergeijk; M E van Meeteren; C J Tak; A P van Dijk; M A Meijssen; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

Review 7.  A Novel Pathway of Flavonoids Protecting against Inflammatory Bowel Disease: Modulating Enteroendocrine System.

Authors:  Mingrui Li; Benno Weigmann
Journal:  Metabolites       Date:  2022-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.